Displaying drugs 1426 - 1450 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Flibanserin | 390.4021 C20H21F3N4O | A 5-HT receptor modulator used for the treatment of selected premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). | Agents that produce hypertension | |
Ximelagatran | 473.5652 C24H35N5O5 | For the treatment of acute deep vein thrombosis. | Antithrombins | |
Milnacipran | 246.354 C15H22N2O | A selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of fibromyalgia and a short-term treatment of major depressive disorder. | Agents producing tachycardia | |
Bepotastine | 388.888 C21H25ClN2O3 | An ophthalmic H1 antagonist used to treat itchiness associated with allergic conjunctivitis. | Anti-Allergic Agents / Histamine H1 Antagonists | |
Enoximone | 248.301 C12H12N2O2S | A selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure. | Phosphodiesterase Inhibitors | |
Vildagliptin | 303.3993 C17H25N3O2 | A once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. | DPP-IV Inhibitors | |
Lorcaserin | 195.69 C11H14ClN | A serotonin 2C receptor agonist used in conjunction with physical activity and calorie restriction for weight loss in obese patients with a body mass index (BMI) of 30 and above, and in overweight patients with weight-related comorbidities. | Centrally Acting Antiobesity Products | |
Nilotinib | 529.5158 C28H22F3N7O | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. | Protein Kinase Inhibitors | |
Omacetaxine mepesuccinate | 545.6213 C29H39NO9 | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. | Antineoplastic Agents | |
Huperzine A | 242.3162 C15H18N2O | Investigated for use/treatment in alzheimer's disease. | Cholinesterase Inhibitors / Neuroprotective Agents | |
Nebivolol | 405.435 C22H25F2NO4 | A beta blocking agent used to treat hypertension and aid in the management of heart failure. | Antihypertensive Agents / Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides | |
Dronedarone | 556.756 C31H44N2O5S | An antiarrhythmic agent used in the reduce the risk of hospitalization in patients with paroxysmal or persistent atrial fibrillation. | Agents that produce hypertension | |
Febuxostat | 316.375 C16H16N2O3S | A xanthine oxidase inhibitor used for the management of chronic hyperuricemia in adults with gout who have an inadequate response or intolerance to allopurinol. | Preparations Inhibiting Uric Acid Production | |
Roxadustat | 352.346 C19H16N2O5 | A hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease. | Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors | |
Celiprolol | 379.501 C20H33N3O4 | A beta-blocker for the management of hypertension and angina pectoris. | Antihypertensive Agents / Beta Blocking Agents, Selective | |
Ixabepilone | 506.7 C27H42N2O5S | A microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. | Microtubule Inhibitors / Tubulin Modulators | |
Tetrabenazine | 317.4226 C19H27NO3 | A vesicular monoamine transporter 2 (VMAT) inhibitor used for the management of chorea associated with Huntington's Disease. | Quinolizines / Vesicular Monoamine Transporter 2 Inhibitor | |
Mepenzolate | 340.436 C21H26NO3 | A postganglionic parasympathetic inhibitor that was previously approved for improving the healing of gastric ulcers, but has been discontinued. | Synthetic Anticholinergics, Quaternary Ammonium Compounds | |
Fluspirilene | 475.5727 C29H31F2N3O | An antipsychotic agent used in the treatment of schizophrenia. | Diphenylbutylpiperidine Derivatives | |
Flunarizine | 404.4948 C26H26F2N2 | A selective calcium-entry blocker used as migraine prophylaxis in patients with severe and frequent episodes who have not responded adequately to more common treatments. | Antivertigo Preparations | |
Debrisoquine | 175.2303 C10H13N3 | For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension. | Guanidine Derivatives | |
Cyproterone acetate | 416.938 C24H29ClO4 | A steroid used in combination with ethinyl estradiol to treat women with severe acne and symptoms of androgenization. Also used alone at much higher doses for palliative treatment of patients with prostate cancer | Antiandrogens and Estrogens | |
Cyclandelate | 276.3707 C17H24O3 | A vasodilator used for the treatment of various blood vessel diseases, such as claudication and arteriosclerosis. | Mandelic Acids / Vasodilating Agents | |
Clofedanol | 289.8 C17H20ClNO | An antitussive used for the symptomatic relief of acute cough caused by minor throat and bronchial irritation. | Alcohols / Amines / Amino Alcohols / Antitussive Agents / Cough and Cold Preparations / Histamine Antagonists / Histamine H1 Antagonists / Propanols | |
Maraviroc | 513.6655 C29H41F2N5O | A CCR5 co-receptor antagonist used with other antiretroviral medications to treat CCR5-tropic HIV-1 infection. | CCR5 Co-receptor Antagonist / CCR5 Receptor Antagonists / Cyclohexanes / HIV Fusion Inhibitors / Triazoles |
Displaying drugs 1426 - 1450 of 2785 in total